{
    "title": "Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer",
    "pmid": "40786508",
    "pmcid": "PMC12331468",
    "study_parameters": [
        {
            "Study Parameters ID": 1454223606,
            "Variant Annotation ID": 1454223600,
            "Study Type": null,
            "Study Cases": 82.0,
            "Study Controls": null,
            "Characteristics": "neuropathy",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.05",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1454223600"
        },
        {
            "Study Parameters ID": 1454223622,
            "Variant Annotation ID": 1454223640,
            "Study Type": null,
            "Study Cases": 82.0,
            "Study Controls": null,
            "Characteristics": "Hematological disorders",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.0005",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1454223640"
        },
        {
            "Study Parameters ID": 1454223621,
            "Variant Annotation ID": 1454223640,
            "Study Type": null,
            "Study Cases": 82.0,
            "Study Controls": null,
            "Characteristics": "neuropathy",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.02",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1454223640"
        },
        {
            "Study Parameters ID": 1454223623,
            "Variant Annotation ID": 1454223652,
            "Study Type": null,
            "Study Cases": 82.0,
            "Study Controls": null,
            "Characteristics": "Hematological disorders",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.005",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1454223652"
        },
        {
            "Study Parameters ID": 1454223659,
            "Variant Annotation ID": 1454223625,
            "Study Type": null,
            "Study Cases": 82.0,
            "Study Controls": null,
            "Characteristics": "Skin and subcutaneous tissue disorders (recessive)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.029",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1454223625"
        },
        {
            "Study Parameters ID": 1454223681,
            "Variant Annotation ID": 1454223701,
            "Study Type": null,
            "Study Cases": 82.0,
            "Study Controls": null,
            "Characteristics": "Mucositis",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.036",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1454223701"
        }
    ],
    "var_drug_ann": [],
    "var_pheno_ann": [
        {
            "Variant Annotation ID": 1454223600,
            "Variant/Haplotypes": "rs1801265",
            "Gene": "DPYD",
            "Drug(s)": "FOLFOX, XELOX",
            "PMID": 40786508,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "Further analysis of ungrouped ADRs indicated a higher risk of neuropathy in patients carrying the C allele of the DPYD rs1801265 polymorphism ( Supplementary Table 3 , codominant model T/C genotype OR = 30.0, p-value = 0.0049, dominant model OR = 4.583, p-value = 0.05).\" Alleles complemented.",
            "Sentence": "Genotypes AG + GG is associated with increased likelihood of Peripheral Nervous System Diseases when treated with FOLFOX or XELOX in people with Colorectal Neoplasms as compared to genotype AA.",
            "Alleles": "AG + GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Peripheral Nervous System Diseases",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Colorectal Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "AA",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40786508",
            "Variant Annotation ID_norm": "1454223600"
        },
        {
            "Variant Annotation ID": 1454223640,
            "Variant/Haplotypes": "rs1695",
            "Gene": "GSTP1",
            "Drug(s)": "FOLFOX, XELOX",
            "PMID": 40786508,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "The G allele of the GSTP1 rs1695 polymorphism was correlated with a lower risk of hematological and nervous system disorders in treated patients, including a reduced risk of neuropathy. This was observed through the analysis of individual ADR using univariate logistic regression without CTCAE v5.0 grouping ( Supplementary Table 3 , OR = 0.01, p-value = 0.008). However, we observed a higher risk of mucositis in patients carrying this polymorphism ( Supplementary Table 3 , OR = 2.27, p-value = 0.036).",
            "Sentence": "Genotype GG is associated with decreased likelihood of Peripheral Nervous System Diseases or Myelosuppression when treated with FOLFOX or XELOX in people with Colorectal Neoplasms as compared to genotypes AA + AG.",
            "Alleles": "GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Peripheral Nervous System Diseases, Side Effect:Myelosuppression",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Colorectal Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "AA + AG",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40786508",
            "Variant Annotation ID_norm": "1454223640"
        },
        {
            "Variant Annotation ID": 1454223652,
            "Variant/Haplotypes": "rs11280056",
            "Gene": "TYMS",
            "Drug(s)": "FOLFOX, XELOX",
            "PMID": 40786508,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "TYMS 3'UTR 6bp deletion (rs11280056) was the only polymorphism associated with a lower risk of severe hematological disorders (dominant model OR = 0,098, CI 95% 0.013 - 0.441, p-value =0.005).",
            "Sentence": "Genotypes TTA/TTA + TTA/TTAAAGTTA is associated with decreased likelihood of Peripheral Nervous System Diseases or Myelosuppression when treated with FOLFOX or XELOX in people with Colorectal Neoplasms.",
            "Alleles": "TTA/TTA + TTA/TTAAAGTTA",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Peripheral Nervous System Diseases, Side Effect:Myelosuppression",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Colorectal Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40786508",
            "Variant Annotation ID_norm": "1454223652"
        },
        {
            "Variant Annotation ID": 1454223625,
            "Variant/Haplotypes": "rs45445694",
            "Gene": "TYMS",
            "Drug(s)": "FOLFOX, XELOX",
            "PMID": 40786508,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "3R genotype of TYMS 5'UTR (rs45445694) is associated as a risk factor for skin and subcutaneous tissue disorders (OR = 6.40; p = 0.029).",
            "Sentence": "Genotype (GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3 is associated with increased likelihood of Hand-foot syndrome, Exanthema or Drug Toxicity when treated with FOLFOX or XELOX in people with Colorectal Neoplasms.",
            "Alleles": "(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Hand-foot syndrome, Side Effect:Exanthema, Side Effect:Drug Toxicity",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Colorectal Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40786508",
            "Variant Annotation ID_norm": "1454223625"
        },
        {
            "Variant Annotation ID": 1454223701,
            "Variant/Haplotypes": "rs1695",
            "Gene": "GSTP1",
            "Drug(s)": "FOLFOX, XELOX",
            "PMID": 40786508,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "The G allele of the GSTP1 rs1695 polymorphism was correlated with a lower risk of hematological and nervous system disorders in treated patients, including a reduced risk of neuropathy. This was observed through the analysis of individual ADR using univariate logistic regression without CTCAE v5.0 grouping ( Supplementary Table 3 , OR = 0.01, p-value = 0.008). However, we observed a higher risk of mucositis in patients carrying this polymorphism ( Supplementary Table 3 , OR = 2.27, p-value = 0.036).",
            "Sentence": "Genotype GG is associated with increased likelihood of Mucositis when treated with FOLFOX or XELOX in people with Colorectal Neoplasms as compared to genotypes AA + AG.",
            "Alleles": "GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Mucositis",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": "or",
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Colorectal Neoplasms",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "AA + AG",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40786508",
            "Variant Annotation ID_norm": "1454223701"
        }
    ],
    "var_fa_ann": []
}